FIERCE study assesses safety of trifluridine/tipiracil with radiation before rectal cancer surgery — Clinical Colorectal Cancer
The phase Ib FIERCE study evaluated the safety of neoadjuvant trifluridine/tipiracil with concurrent radiation in resectable stage II/III rectal cancer. This trial explores whether this oral chemotherapy drug can be safely combined with radiation therapy before surgery.